Relief Therapeutics

Switzerland - GenevaBiotechnology1 H-1B visas (FY2023)

Focus: Relief Therapeutics is a Swiss biotech company specializing in peptide and protein therapies focused on addressing unmet medical needs. The company operates as a development-stage biotechnology firm with a European base.

Infectious Diseases Metabolic Diseases Vaccines

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Relief Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Relief Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

44 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Universal ART in a streamlined care model

HIV

N/A

Clinical Trials (1)

NCT01864603Sustainable East Africa Research in Community Health

N/A

Help build intelligence for Relief Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused therapeutic area (peptides & proteins) offers deep specialization opportunity in a growing modality
Switzerland location provides access to strong biotech ecosystem and quality-of-life benefits
Early-stage company structure allows for broader impact and direct influence on strategic decisions

Watch Out For

No active clinical trials reported; pipeline maturity and clinical progress are unclear, limiting near-term catalysts
Zero current open positions and minimal public hiring activity suggest limited near-term growth or expansion

Generated by Claude from Relief Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Lidocaine

Trigeminal Neuralgia

N/A

Clinical Trials (1)

NCT01955967The Effect of Intravenous Lidocaine on Trigeminal Neuralgia

N/A

Minimally Invasive Lumbar Decompression

Lumbar Spinal Stenosis

N/A

Signal Relief Patch

Musculoskeletal Pain

N/A

Clinical Trials (1)

NCT05288114Signal Relief Patch in Musculoskeletal Pain

N/A

A mobile app with AI functionality for diagnosing skin-related NTDs

Skin and Connective Tissue Diseases

N/A

Clinical Trials (1)

NCT07506967Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

N/A

Group self-management support program for anxiety disorders

Panic Disorder

N/A

Clinical Trials (1)

NCT05124639Clinical Trial of a Group Self-management Support Program for Anxiety Disorders

N/A

Exposure to Growth Mats

Stunting

N/A

Clinical Trials (1)

NCT04579328Impact of Life-size Growth Charts on Understanding of Stunting

N/A

Home-based ECD services

Early Childhood Development in HIV-Exposed Children

N/A

Clinical Trials (1)

NCT03195036Evaluation of an Early Childhood Development Intervention for HIV-Exposed Children in Cameroon

N/A

Standard intervention: Offer PrEP choice

Oral Pre-exposure Prophylaxis (PrEP)

N/A

Clinical Trials (1)

NCT06319105PathToScale: An Implementation Evaluation

N/A

Acceptability of OraQuick Advance© Rapid HIV-1/2 Antibody screening

HIV Testing

N/A

Clinical Trials (1)

NCT04774666Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Uganda

N/A

Biosound Therapy System

Long COVID

N/A

Clinical Trials (1)

NCT05848401Biosound Therapy as a Treatment for Long COVID Patients

N/A

Artesunate + Amodiaquine Fixed Dose Combination

Fever

N/A

Clinical Trials (1)

NCT00612547ACT for the Home Management in Malagasy Children

N/A

UroRelief, a sterile, single-use, endourethral medical device suitable for both men and women, which is positioned at the bladder neck for the treatment of stress incontinence.

Urinary Incontinence , Stress

N/A

Clinical Trials (1)

NCT07327528Monocentric Pilot Study for the Application of an Endourethral Device for the Treatment of Stress Urinary Incontinence

N/A

Standard of Care

Oral Pre-exposure Prophylaxis (PrEP)

N/A

Clinical Trials (1)

NCT07221747PathToScale: The PERSIST Trial

N/A

Full TP intervention

Child Marriage

N/A

Clinical Trials (1)

NCT04015856Preventing Early Child Marriage in Nepal

N/A

Interossei Lumbricals Neuro Interface

Carpal Tunnel Syndrome

N/A

Clinical Trials (1)

NCT02101294Study Protocol for CTS and Keyboard Controlled Randomized Trial

N/A

Transfluthrin - delivery by paid study personnel

Malaria

N/A

Clinical Trials (1)

NCT06122142Spatial Repellents for Malaria Control

N/A

Relief implantation

Urinary Incontinence

N/A

Clinical Trials (1)

NCT05449639Study for a Magnetic Endourethral Sphincter Against Stress Urinary Incontinence

N/A

Transfluthrin

Malaria

N/A

Clinical Trials (1)

NCT04795648Spatial Repellents for Vector Control

N/A

mHealth intervention

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT03580330Use of Low-cost mHealth Intervention to Enhance Outcomes of Noncommunicable Diseases Care in Rural and Refugee Settings

N/A

Lyric Hearing Aid- Experimental Design

Hearing Loss

N/A

Clinical Trials (1)

NCT05274165Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology

N/A

Brilliance

Jaundice, Neonatal

N/A

Clinical Trials (1)

NCT03184948Understanding Neonatal Jaundice in Rwanda

N/A

modified directly observed therapy

Acquired Immunodeficiency Syndrome

N/A

Clinical Trials (1)

NCT00272220Longitudinal Study of HAART, Social Networks, & Adherence

N/A

Enhanced CHW intervention

Mother-to-child Transmission of HIV

N/A

Clinical Trials (1)

NCT01932138Trial to Improve Access to PMTCT Services and Reduce HIV Transmission From Mother to Child

N/A

Community score card approach

HIV/AIDS

N/A

Clinical Trials (1)

NCT04372667Adaptation and Evaluation of the PMTCT CSC in Dedza and Ntcheu Districts, Malawi

N/A

Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM

HIV Testing

N/A

Clinical Trials (1)

NCT01637324Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM

N/A

Control

Escherichia Coli Change

N/A

Clinical Trials (1)

NCT04312334Improving the Supertowel: An Alternative Hand Cleaning Product for Emergencies

N/A

Standard of Care + EMMA

HIV

N/A

Clinical Trials (1)

NCT02848235Kenya Enhanced Mentor Mother ProgrAm (EMMA)

N/A

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Tuberculosis

N/A

Clinical Trials (1)

NCT01539005Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

N/A

Acceptability of OraQuick Advance© Rapid HIV-1/2 Antibody screening Oral fluid-based HIV test

HIV Testing

N/A

Clinical Trials (1)

NCT04754386Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Zambia

N/A

Corn Soya Blend+

Maternal and Newborn Health

N/A

Clinical Trials (1)

NCT01413776Effects of a Fortified Dietary Supplement for Pregnant Women on Maternal and Newborn Outcomes in Kampong Chhnang Province, Cambodia

N/A

Conditional Cash Transfer

Vaccination

N/A

Clinical Trials (1)

NCT00966849Manicaland Cash Transfer Trial for Children in Zimbabwe

N/A

Outcome Measures for Pediatric Wheelchairs in Low-resource Settings

Shoulder Impingement

N/A

Clinical Trials (1)

NCT01530425Outcome Measures for Pediatric Wheelchairs in Low-resource Settings

N/A

Enhanced TB IC Package

Tuberculosis

N/A

Clinical Trials (1)

NCT02073240Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand

N/A

PrEP Cohort

HIV/AIDS

N/A

Clinical Trials (1)

NCT04044235Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women

N/A

Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

HIV-1-infection

N/A

Clinical Trials (1)

NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

N/A

Integrated Mothers and Babies Course

Early Childhood Development

N/A

Clinical Trials (1)

NCT03665246Evaluation of the iMBC/ECD Model in Ghana

N/A

Moments that Matter

Child Development

N/A

Clinical Trials (1)

NCT05796934Evaluation of the Moments That Matter Program in Kenya

N/A

Point of care CD4 device

HIV

N/A

Clinical Trials (1)

NCT02515149Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

N/A

Prednisolone

HIV Disease Progression

Phase 2

Clinical Trials (1)

NCT01299948Progression of HIV-Disease Under Low Dose Corticosteroids

Phase 2

Malaria Rapid Diagnostic test

Malaria

Phase 4

Clinical Trials (1)

NCT01403350Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan

Phase 4

7-valent pneumococcal conjugated vaccine

Infectious Disease

Phase 4

Clinical Trials (1)

NCT02040402Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7

Phase 4

Initiating daily oral PrEP during pregnancy

Pre-exposure Prophylaxis

Phase 4

Clinical Trials (1)

NCT06158126UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study

Phase 4

Rapid diagnostic test

Malaria

Phase 4

Clinical Trials (1)

NCT00935688Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area

Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 43 clinical trials

Top TAs: Infectious Diseases, Cardiovascular, Metabolic Diseases

H-1B (2023): 1 approval

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

21 pipeline

2 pipeline

2 pipeline

1 pipeline

1 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub